# S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

> **NCT00049400** · PHASE1 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 78 (actual)

## Conditions studied

- Lymphoma
- Small Intestine Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** BMS-247550

## Key facts

- **NCT ID:** NCT00049400
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2006-09
- **Final completion:** 2007-12
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2015-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00049400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00049400, "S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00049400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*